LexaGene Holdings Inc. Quarterly Earnings Per Share, Diluted in USD/shares from Q3 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
LexaGene Holdings Inc. quarterly Earnings Per Share, Diluted history and growth rate from Q3 2021 to Q4 2022.
  • LexaGene Holdings Inc. Earnings Per Share, Diluted for the quarter ending November 30, 2022 was -0.01 USD/shares, a 50% increase year-over-year.
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $0 +$0.01 +50% Sep 1, 2022 Nov 30, 2022 10-Q 2023-01-17
Q3 2022 $0 $0 0% Jun 1, 2022 Aug 31, 2022 10-Q 2022-10-18
Q4 2021 $0 Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-17
Q3 2021 $0 Jun 1, 2021 Aug 31, 2021 10-Q 2022-10-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.